Hims & Hers Health Inc. Q3 2025 Earnings Report: Revenue and Subscriber Growth Surpass Expectations
Hims & Hers Health Inc. released its Q3 2025 earnings report, with revenue reaching USD 600 million, surpassing the IBES estimate of USD 579.3 million and marking a 49% year-over-year growth. The company achieved a net income of USD 16 million and an EPS of USD 0.06, despite market expectations of a 44% drop in adjusted EPS. Key focus areas include revenue growth, gross margin execution, and EPS improvement amidst regulatory disruptions. The outlook for the full year includes revenue in the range of USD 2,335-2,355 million and adjusted EBITDA between USD 307-317 million. Additionally, free cash flow remained stable at $79.4 million, and discussions with Novo Nordisk are ongoing for potential offerings pending FDA approval.